Larry Biegelsen
Stock Analyst at Wells Fargo
(3.61)
# 840
Out of 5,002 analysts
331
Total ratings
51.48%
Success rate
5.51%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Overweight | $93 → $72 | $69.12 | +4.17% | 18 | Aug 28, 2025 | |
| MDT Medtronic | Maintains: Overweight | $98 → $100 | $95.48 | +4.73% | 18 | Aug 20, 2025 | |
| HYPR Hyperfine | Maintains: Equal-Weight | $0.68 → $0.85 | $1.43 | -40.56% | 6 | Aug 15, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $20 → $13 | $13.11 | -0.84% | 10 | Aug 7, 2025 | |
| EW Edwards Lifesciences | Maintains: Overweight | $84 → $88 | $76.65 | +14.81% | 17 | Aug 7, 2025 | |
| ALC Alcon | Reinstates: Equal-Weight | $93 | $75.11 | +23.82% | 9 | Aug 6, 2025 | |
| INSP Inspire Medical Systems | Maintains: Equal-Weight | $174 → $101 | $74.09 | +36.32% | 13 | Aug 5, 2025 | |
| SYK Stryker | Maintains: Overweight | $435 → $445 | $366.40 | +21.45% | 16 | Aug 1, 2025 | |
| TFX Teleflex | Maintains: Equal-Weight | $137 → $131 | $125.50 | +4.38% | 6 | Aug 1, 2025 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $6 → $3 | $1.69 | +77.51% | 7 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $24 | $23.23 | +3.31% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $86 → $92 | $84.49 | +8.89% | 15 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $15 | $14.76 | +1.63% | 7 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $108 → $100 | $82.46 | +21.27% | 11 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $315 → $290 | $253.49 | +14.40% | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $40 → $15 | $14.05 | +3.20% | 18 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $118 → $124 | $96.22 | +28.87% | 14 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $559 → $599 | $443.01 | +35.21% | 20 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $27 | $24.35 | +10.88% | 2 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $25 → $9 | $8.56 | +5.14% | 14 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $113 → $98 | $99.17 | -1.18% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $89 | $76.82 | +15.86% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $10.43 | +62.99% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $166 → $152 | $185.98 | -18.27% | 13 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $94 | $66.44 | +41.48% | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $13.97 | +250.75% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $132.99 | +2.26% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $58.06 | +20.56% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $191.60 | +40.92% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $52.69 | - | 2 | Nov 2, 2017 |
The Cooper Companies
Aug 28, 2025
Maintains: Overweight
Price Target: $93 → $72
Current: $69.12
Upside: +4.17%
Medtronic
Aug 20, 2025
Maintains: Overweight
Price Target: $98 → $100
Current: $95.48
Upside: +4.73%
Hyperfine
Aug 15, 2025
Maintains: Equal-Weight
Price Target: $0.68 → $0.85
Current: $1.43
Upside: -40.56%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $20 → $13
Current: $13.11
Upside: -0.84%
Edwards Lifesciences
Aug 7, 2025
Maintains: Overweight
Price Target: $84 → $88
Current: $76.65
Upside: +14.81%
Alcon
Aug 6, 2025
Reinstates: Equal-Weight
Price Target: $93
Current: $75.11
Upside: +23.82%
Inspire Medical Systems
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $174 → $101
Current: $74.09
Upside: +36.32%
Stryker
Aug 1, 2025
Maintains: Overweight
Price Target: $435 → $445
Current: $366.40
Upside: +21.45%
Teleflex
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $137 → $131
Current: $125.50
Upside: +4.38%
Pulmonx
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $6 → $3
Current: $1.69
Upside: +77.51%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $33 → $24
Current: $23.23
Upside: +3.31%
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $86 → $92
Current: $84.49
Upside: +8.89%
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $12 → $15
Current: $14.76
Upside: +1.63%
Jul 31, 2025
Maintains: Overweight
Price Target: $108 → $100
Current: $82.46
Upside: +21.27%
Jul 30, 2025
Maintains: Overweight
Price Target: $315 → $290
Current: $253.49
Upside: +14.40%
Jul 25, 2025
Downgrades: Equal-Weight
Price Target: $40 → $15
Current: $14.05
Upside: +3.20%
Jul 24, 2025
Maintains: Overweight
Price Target: $118 → $124
Current: $96.22
Upside: +28.87%
Jul 23, 2025
Maintains: Overweight
Price Target: $559 → $599
Current: $443.01
Upside: +35.21%
Jul 17, 2025
Maintains: Overweight
Price Target: $28 → $27
Current: $24.35
Upside: +10.88%
Jul 9, 2025
Downgrades: Equal-Weight
Price Target: $25 → $9
Current: $8.56
Upside: +5.14%
May 6, 2025
Maintains: Equal-Weight
Price Target: $113 → $98
Current: $99.17
Upside: -1.18%
May 1, 2025
Maintains: Overweight
Price Target: $103 → $89
Current: $76.82
Upside: +15.86%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $10.43
Upside: +62.99%
Jan 23, 2025
Maintains: Equal-Weight
Price Target: $166 → $152
Current: $185.98
Upside: -18.27%
Dec 11, 2024
Maintains: Overweight
Price Target: $90 → $94
Current: $66.44
Upside: +41.48%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $13.97
Upside: +250.75%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $132.99
Upside: +2.26%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $58.06
Upside: +20.56%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $191.60
Upside: +40.92%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $52.69
Upside: -